Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Augment Rare Disease Services is a specialized service provider dedicated to supporting the rare disease community through clinical trial recruitment, patient engagement, and advocacy. The company bridges the gap between biopharmaceutical sponsors and patient populations by leveraging deep expertise in the unique challenges of rare disease drug development. Their services include patient identification, site support, and the development of patient-centric clinical trial strategies to accelerate the delivery of orphan drugs. By focusing exclusively on rare conditions, Augment RDS helps streamline the path from clinical research to commercial availability for underserved patient groups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Augment Rare Disease Services.